Lead Pharma enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases

LifeSpring Life Sciences Communication,?Amsterdam
Leon Melens
Tel.: +31 (0) 6 538 16 427
Lmelens(at)lifespring.nl Company Inquiries: Lead Pharma Holding B.V.
Frans van den Berg, MSc MBA
Chief Executive Officer
Tel.: +31 412 782999
BD@leadpharma.com SOURCE Lead Pharma